Diagnostic potential of urinary PENK methylation for bladder cancer in patients with hematuria: insights from a prospective and multi-institutional study

Dai Koguchi, Izuru Shiba, Yutaka Shiono, Kazumasa Matsumoto · 2026

Read Diagnostic potential of urinary PENK methylation for bladder cancer in patients with hematuria: insights from a prospective and multi-institutional study by Dai Koguchi, Izuru Shiba, Yutaka Shiono, Kazumasa Matsumoto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13263808.txt.

Description

Dai Koguchi and colleagues commented in 2026 on a urine test that could spare many patients with bloody urine an invasive bladder inspection. The test reads methylation of the PENK gene in urine, a chemical switch that silences the gene in several cancers. Their commentary examines a large prospective study run across ten Korean institutions.

That study enrolled patients with hematuria prospectively and sized its cohort from pilot accuracy figures. Earlier single-center work had hinted the marker performs best for high-grade and advanced tumors, precisely the dangerous ones. The commentators weigh the design strengths against what clinics would need before adopting the test. They frame urinary methylation testing as a credible route to fewer unnecessary cystoscopies. Remaining questions include cost, workflow, and how the marker combines with existing tools.

Catalog record

CREATORDai Koguchi, Izuru Shiba, Yutaka Shiono, Kazumasa Matsumoto
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13263808

Browse the full library · About the Tower of Babel